| Name | Title | Contact Details |
|---|
Recognized as a disruptor in the health industry, dosist is setting a new standard in access to natural plant-based health and wellness solutions. Through our award-winning products, we provide consistent, targeted formulas and precise dosage, allowing people to experience the benefits of cannabis-based therapy in an effective and predictable way.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Queens-Long Island Medical Group, P.C. is a Garden City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CRS Medical Technologies is a New Berlin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Protectus Medical Devices is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.